Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs

Autor: Jesús Horacio Lara-Puente, Juan Manuel Carreño, Weina Sun, Alejandro Suárez-Martínez, Luis Ramírez-Martínez, Francisco Quezada-Monroy, Georgina Paz-De la Rosa, Rosalía Vigueras-Moreno, Gagandeep Singh, Oscar Rojas-Martínez, Héctor Elías Chagoya-Cortés, David Sarfati-Mizrahi, Ernesto Soto-Priante, Constantino López-Macías, Florian Krammer, Felipa Castro-Peralta, Peter Palese, Adolfo García-Sastre, Bernardo Lozano-Dubernard

Publikováno v: mBio, Vol 12, Iss 5 (2021)

Several highly efficacious vaccines for SARS-CoV-2 have been developed and are used in the population. However, the current production capacity cannot meet the global demand. Therefore, additional vaccines—especially ones that can be produced local

Externí odkaz: https://doaj.org/article/d47ce303ae344529b5dda46a5d3fc757

Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs

Autor: David Sarfati-Mizrahi, Bernardo Lozano-Dubernard, Héctor Elías Chagoya-Cortés, Rosalía Vigueras-Moreno, Peter Palese, Florian Krammer, Constantino López-Macías, Oscar Rojas-Martínez, Francisco Quezada-Monroy, Felipa Castro-Peralta, Juan Manuel Carreño, Ernesto Soto-Priante, Adolfo García-Sastre, Weina Sun, Alejandro Suárez-Martínez, Gagandeep Singh, Luis Ramírez-Martínez, Georgina Paz-De la Rosa, Jesus Horacio Lara-Puente

Publikováno v: mBio, Vol 12, Iss 5 (2021)
mBio

Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were developed in record time and show excellent efficacy and effectiveness against coronavirus disease 2019 (COVID-19). However, currently approved vaccines cannot meet th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc345961fcf6785368dd7a1928cfd35e
https://journals.asm.org/doi/10.1128/mBio.01908-21

Primer aislamiento e identificación de Ureaplasma spp y de Mycoplasma lipofaciens de gallinas comerciales en México

Autor: Ernesto Soto Priante, Clemente Lemus Flores, Ariel Ortiz Muñíz

Publikováno v: Revista Mexicana de Ciencias Pecuarias, Vol 2, Iss 1, Pp 85-92 (2011)
Universidad Nacional Autónoma de México
UNAM
Redalyc-UNAM
Revista Mexicana de Ciencias Pecuarias (México) Num.1 Vol.2

"Durante un estudio realizado en México durante los años 2003 y 2004 se realizó el aislamiento de Ureaplasma spp (U. spp) y de Mycoplasma lipofaciens (M. lipofaciens) de la porción superior de la tráquea de aves comerciales vivas y sanas tipo Wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::422a6f38707d6354fb7a1d0eb0cb9aae
http://www.redalyc.org/articulo.oa?id=265619707008

Protective Dose of a Recombinant Newcastle Disease Lasota–Avian Influenza Virus H5 Vaccine Against H5N2 Highly Pathogenic Avian Influenza Virus and Velogenic Viscerotropic Newcastle Disease Virus in Broilers with High Maternal Antibody Levels

Autor: Bernardo Lozano-Dubernard, Ernesto Soto-Priante, Manuel Joaquin Gay-Gutierrez, Ricardo Flores-Castro, David Sarfati-Mizrahi, Felipa Castro-Peralta, Elizabeth Loza-Rubio

Publikováno v: Avian Diseases Digest. 5:e21-e22

The protective dose of a live recombinant LaSota Newcastle disease virus (NDV)-avian influenza H5 vaccine (rNDV-LS/AI-H5) was determined in broiler chickens with high levels of maternal antibodies against NDV and avian influenza virus (AIV). At hatch

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d549c125fd1cdc17f7e6269905d1655
https://doi.org/10.1637/9126-873509-digest.1